You are here: Industry Insights > Bayer

News List

Pistoia Alliance, backed by Roche, AZ and Bayer, to Introduce FAIR Project contractpharma
July 17, 2019
Includes a toolkit to help companies implement the FAIR guiding principles.
LEO Pharma completes the acquisition of Bayer’s prescription dermatology business worldpharmanews
July 03, 2019
LEO Pharma completes the acquisition of Bayer’s prescription dermatology business.
LEO Pharma Completes Acquisition of Bayer’s Prescription Dermatology Business americanpharmaceuticalreview
July 03, 2019
LEO Pharma and Bayer announced the achievement of the relevant closing conditions to allow the transfer of Bayer’s global prescription dermatology business to LEO Pharma.
FOGSI and Bayer launch care guidelines on endometriosis for doctors expressbpd
June 27, 2019
VISION (Valuable Insights in Indian Endometriosis- Redefining Outcomes) will help address the challenges faced by physicians in the field of endometriosis
Regorafenib to be tested in brain cancer patients in multi-arm cooperation trial worldpharmanews
June 24, 2019
Regorafenib to be tested in brain cancer patients in multi-arm cooperation trial.
CStone and Bayer to evaluate PD-L1 monoclonal antibody CS1001 in combination with regorafenib biospectrumasia
June 10, 2019
Combination therapy of PD-1/PD-L1 antibodies with multi-kinase inhibitors that target VEGFR can induce significant synergistic anti-tumour effects, demonstrating CS1001 immuno-oncology potential in patients suffering from gastric cancer and serious malign
Bayer receives U.S. FDA breakthrough therapy designation for copanlisib for the treatment of marginal zone lymphoma worldpharmanews
May 30, 2019
Bayer announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for copanlisib (Aliqopa™) for the treatment of adult patients with ...
Bayer presents New Analyses for Vitrakvi® americanpharmaceuticalreview
May 17, 2019
Bayer announced findings from new analyses and data for Vitrakvi® (larotrectinib), which is approved for the treatment of adult and pediatric patients with solid tumors that have a neurotrophic tropomyosin receptor kinase (NTRK) gene fusion without ...
Bayer to invest $150m in building biological therapies facility pharmaceutical-technology
May 14, 2019
Bayer has committed $150m to build a cell culture technology centre at its pharmaceutical development and manufacturing site in Berkeley, California, US.
Bayer joins Sensyne Health consortium for accelerating new medicine discovery pharmatimes
May 10, 2019
Bayer joins Sensyne Health consortium for accelerating new medicine discovery.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page